Do you want to read an article? Please log in or register.
Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease
Inflammatory Bowel Disease
Related content
Colonoscopy
Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence
World J Gastroenterol.
Baillet P, Cadiot G, Goutte M, Goutorbe F, Brixi H, Hoeffel C, Allimant C, Reymond M, Obritin-Guilhen H, Magnin B, Bommelaer G, Pereira B, Hordonneau C, Buisson A
doi: 10.3748/wjg.v24.i5.641.
Inflammatory Bowel Disease
Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis
J Crohns Colitis.
Hart L, Chavannes M, Kherad O, Maedler C, Mourad N, Marcus V, Afif W, Bitton A, Lakatos PL, Brassard P, Bessissow T
doi: 10.1093/ecco-jcc/jjz107.
Inflammatory Bowel Disease
Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease
Inflamm Bowel Dis.
Osterman MT, Gordon IO, Davis EM, Ciorba M, Glover SC, Abraham B, Khan F, Guo X, Yee EU, Allard FD, Claggett B, Shen B, Liu JJ
doi: 10.1093/ibd/izz222.
Inflammatory Bowel Disease
Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis
Z Gastroenterol.
Hüppe A, Langbrandtner J, Häuser W, Raspe H, Bokemeyer B
doi: 10.1055/a-0605-4080.
RECOMMENDED
Inflammatory Bowel Disease
Week 6 Calprotectin Best Predicts Likelihood of Long-Term Endoscopic Healing in Crohn's Disease: A Post-Hoc Analysis of the UNITI/IM-UNITI Trials
★ 2
Recommended by
PD Dr Luc Biedermann, Faculty Member
J Crohns Colitis
Narula N, Wong ECL, Dulai PS, Marshall JK, Colombel JF, Reinisch W
doi: 10.1093/ecco-jcc/jjaa189
Inflammatory Bowel Disease
Fecal biomarkers in inflammatory bowel diseases: calprotectin versus lipocalin-2 - a comparative study
J Crohns Colitis.
Zollner A, Schmiderer A, Reider SJ, Oberhuber G, Pfister A, Texler B, Watschinger C, Koch R, Effenberger M, Raine T, Tilg H, Moschen AR
doi: 10.1093/ecco-jcc/jjaa124.
Inflammatory Bowel Disease
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study
Inflamm Bowel Dis.
Reinisch W, Panaccione R, Bossuyt P, Baert F, Armuzzi A, Hébuterne X, Travis S, Danese S, Sandborn WJ, Schreiber S, Berg S, Zhou Q, Kligys K, Neimark E, Suleiman AA, D'Haens G, Colombel JF
doi: 10.1093/ibd/izaa025.
Inflammatory Bowel Disease
Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study
doi: 10.1093/ecco-jcc/jjy183.
Inflammatory Bowel Disease
Cannabis for the treatment of Crohn's disease
Cochrane Database Syst Rev.
Kafil TS, Nguyen TM, MacDonald JK, Chande N
doi: 10.1002/14651858.